FDA.reportPublic FDA data

Application 020729

Type
NDA
Sponsor
UCB INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001UNIRETICHYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDETABLET;ORAL12.5MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**NoNo
002UNIRETICHYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDETABLET;ORAL25MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**NoNo
003UNIRETICHYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDETABLET;ORAL12.5MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**NoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
25652SUPPL2012-09-17
35246SUPPL2012-09-14
35245SUPPL2012-01-23
3220SUPPL2012-01-23
13305SUPPL2011-09-02
25651SUPPL2011-08-26
35244SUPPL2011-05-23
35243SUPPL2010-01-20
25650SUPPL2010-01-15
20885SUPPL2007-09-26
25649SUPPL2003-11-25
3219SUPPL2002-02-14